Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Meheco Great Wall Pharma is a key manufacturing subsidiary of China Meheco Group Co., Ltd., a major state-owned enterprise under the China General Technology Group. Based in Beijing, the company focuses on the production of chemical drugs and traditional Chinese medicine (TCM) formulations, including oral liquids, tablets, and capsules. It is particularly well-known for its respiratory products, such as Compound Glycyrrhiza Oral Solution, and maintains high-standard GMP manufacturing facilities. The company plays a vital role in the parent group's integrated pharmaceutical supply chain, covering R&D, production, and international trade. Its products are distributed both within China and to various international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Meheco Great Wall Pharma.